(Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor
US7700634B2 · kind B2 · utility
2Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 2005 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | Feb 28, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed herein are indole derivatives of the formula (I)wherein each of the substitutents is given the definition as set forth in the specification and claims. Also disclosed are pharmaceutical compositions containing the indole derivatives and use of the derivatives for the treatment of pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.